Accéder au contenu
Merck

Novel lipoidal amine-based nanocarrier formulations for siRNA delivery.

Therapeutic delivery (2012-07-31)
Chenguang Zhou, Zhang Yue, L James Lee, Robert J Lee
RÉSUMÉ

Lack of safe and efficient delivery of siRNA remains the greatest hurdle for the therapeutic application of siRNA. This article reports synthesis and evaluation of novel lipoidal amine-based nanocarrier (LANC) formulations for siRNA delivery. Physicochemical properties were analyzed for LANC formulations. siRNA delivery efficiency of LANC-siRNA complexes was determined using a luciferase reporter gene assay. Cytotoxicity of the LANC-siRNA complexes was measured by the MTS assay. Finally, cellular uptake and cytoplasmic release of siRNA were analyzed using flow cytometry. The LANC formulation facilitated siRNA uptake and release into the cytoplasm, mediating significant luciferase knockdown (70% inhibition).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Avridine, ≥97% (HPLC)